The tariff classification of Alprazolam Tablets, Hydoxyzine Hydrochloride Tablets, Baclofen Tablets, Metoclopramide Hydrochloride Tablets and Furosemide Tablets from India
Reasoning
The tariff classification of Alprazolam Tablets, Hydoxyzine Hydrochloride Tablets, Baclofen Tablets, Metoclopramide Hydrochloride Tablets and Furosemide Tablets from India
Cite this ruling
CBP Ruling N006189 (3004909135): The tariff classification of Alprazolam Tablets, Hydoxyzine Hydrochloride Tablets, Baclofen Tablets, Metoclopramide Hydrochloride Tablets and Furosemide Tablets from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of acetaminophen tablets and caplets from China
The tariff classification of children’s aspirin tablets, enteric-coated aspirin tablets, and calcium carbonate antacid tablets from China
The tariff classification of children’s aspirin tablets, enteric-coated aspirin tablets, and calcium carbonate antacid tablets from China
The tariff classification of ANTEGREN® (natalizumab) mixed with excipients and imported in bulk form, and ANTEGREN® (natalizumab) mixed with excipients and imported put up in single-dose vials, from Germany and other countries
Modification of New York Ruling Letter (NYRL) K84840, dated April 20, 2004, concerning cherry flavored cough suppressant lozenge